Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Régine Rouzier-Panis"'
Autor:
Jacques Reynes, Valérie Pinet, Régine Rouzier-Panis, Jacques Clot, Pierre Corbeau, Pierre Portales, Vincent Baillat
Publikováno v:
AIDS. 17:495-504
OBJECTIVE The percentage and the activity of natural killer (NK) cells are known to be decreased in HIV-infected patients. However, the mechanisms responsible for this NK deficiency are poorly understood. Because of the role of NK cells in the host d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a2a77ba984f6813465e4d0d9fe08322
https://doi.org/10.1097/00002030-200303070-00004
https://doi.org/10.1097/00002030-200303070-00004
Perforin expression in T cells and virological response to PEG-interferon alpha2b in HIV-1 infection
Autor:
Pierre Portales, Pierre Corbeau, Jacques Clot, Vincent Baillat, Régine Rouzier-Panis, Jacques Reynes
Publikováno v:
AIDS (London, England). 17(4)
Objective and design Interferon alpha (IFNalpha), which is known to directly inhibit the HIV-1 replicative cycle and to increase the activity of cytotoxic T lymphocytes (CTL), is being tested as an anti-HIV agent. As CTL play a major role in immune d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aef48e890e71467df7e3ac8847c0495d
https://pubmed.ncbi.nlm.nih.gov/12598770
https://pubmed.ncbi.nlm.nih.gov/12598770
Autor:
Keith Nieforth, Jean-Marie Lang, Indravadan H. Patel, Xiaoping Zhang, Tosca Kinchelow, Stanley J. Kolis, Jacques Reynes, Régine Rouzier-Panis, Albert Dorr, Mark R. Stiles
Publikováno v:
Clinical pharmacology and therapeutics. 72(1)
Objective Enfuvirtide (T-20) is the first of a novel class of human immunodeficiency virus (HIV) drugs that block gp41-mediated viral fusion to host cells. The objectives of this study were to develop a structural pharmacokinetic model that would ade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::824daaf23fcf16bd4a84f33818574ebf
https://pubmed.ncbi.nlm.nih.gov/12152000
https://pubmed.ncbi.nlm.nih.gov/12152000
Autor:
Didier, Bessis, Audrey, Charron, Régine, Rouzier-Panis, Véronique, Blatière, Jean-Jacques, Guilhou, Jacques, Reynes
Publikováno v:
European journal of dermatology : EJD. 12(1)
Pegylated interferon alfa is a pegylated formulation of recombinant human interferon (IFN) conjugated with polyethylene-glycol (PEG). The major advantages of this formulation, compared to standard IFN, is a prolonged half-life which allows for once-w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f9ab0b7250ec517c9808691e17bec604
https://pubmed.ncbi.nlm.nih.gov/11809610
https://pubmed.ncbi.nlm.nih.gov/11809610
Autor:
Neasa Harding, Paul Chevalier, Jacques Rey, Régine Rouzier-Panis, G. Montay, Olivier Pasquier
Publikováno v:
Journal of clinical pharmacology. 41(4)
Quinupristin/dalfopristin (Q/D) is a novel streptogramin antibiotic for the treatment of severe gram-positive infections. The purpose of this open, nonrandomized, parallel-group, phase I trial was to evaluate Q/D pharmacokinetics after single and rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b15386e79844f571c998bbae4f928e4c
https://pubmed.ncbi.nlm.nih.gov/11304897
https://pubmed.ncbi.nlm.nih.gov/11304897
Autor:
Paul Glue, Claude Raffanel, Régine Rouzier-Panis, Margaret Salfi, Shiela Jacobs, Samir K. Gupta, Ron Sabo, Robert P. Clement
Publikováno v:
Scopus-Elsevier
The objectives of this study were to assess the safety, pharmacokinetics, and efficacy of pegylated interferon alfa-2b (PEG-Intron) plus ribavirin in patients with chronic hepatitis C. A total of 72 patients (35 men/37 women, age range 20-68 years) w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f235932b1b6de2a1c1625875b3ee1526
http://www.scopus.com/inward/record.url?eid=2-s2.0-0033844251&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0033844251&partnerID=MN8TOARS
